Biotechnology Digital Health Avenna Medtech start-up specialising in precision medicine tools to tackle chronic inflammatory diseases
Founded: 2017
https://avenna.com See More at NOAH Connect KEY CORPORATE FACTS BUSINESS OVERVIEW Avenna is a MedTech start up specializing on precision medicine solutions for early detection, prevention and treatments for chronic inflamma- Headquarters Oxford, United Kingdom tory diseases ( “CIDs”). We are a spin out from Oxford’ based company, Ludger, which has been innovating in the field of glycotechology for the Active Markets United Kingdom last 20 years. At Avenna we work alongside scientists, clinicians, corporations and patients to enable successful translation of most promising of research grade technologies into practical biomarkers, tests and pathways for chronic inflammatory diseases ( “CID”). Our initial focus is on… Employees 1-3 READ MORE Ownership Founders Total Funding € 0.2m NOAH LONDON STARTUP BOOK 5